Successful heart transplantation for COVID‐19‐associated post‐infectious fulminant myocarditis

ESC Heart Failure

Baptiste Gaudriot¹  Nicolas Nesseler¹  Alexandre Mansour¹  Guillaume Leurent²  Bernard Lelong²  Aurélie Cauchois³  James T. Ross⁴  Jean‐Marc Tadié⁵  Jean‐Philippe Verhoye⁵  Mathieu Lederlin⁵  Matthieu Revest⁵  Vincent Thibault⁵  Erwan Flecher⁵ 

[1] Department of Anesthesia and Critical Care University Hospital of Rennes Rennes F‐35000 France;Department of Cardiology University Hospital of Rennes Rennes France;Department of Pathology University Hospital of Rennes Rennes France;Department of Surgery University of California San Francisco CA USA;Univ Rennes, CHU de Rennes Rennes France;

关键词: Fulminant myocarditis;    COVID‐19;    Cardiogenic shock;    Extracorporeal membrane oxygenation;    Heart transplantation;   

DOI  :  10.1002/ehf2.13326

来源: DOAJ

【 摘 要 】

Abstract Various clinical presentations of the 2019 coronavirus disease (COVID‐19) have been described, including post‐infectious acute and fulminant myocarditis. Here, we describe the case of a young patient admitted for COVID‐19‐associated post‐infectious fulminant myocarditis. Despite optimal pharmacologic management, haemodynamic status worsened requiring support by veno‐arterial extracorporeal membrane oxygenation. Emergent heart transplantation was required at Day 11 given the absence of cardiac function improvement. The diagnosis of post‐infectious COVID‐19‐associated myocarditis was made from both pathologic examination of the explanted heart and positive SARS‐CoV‐2 serology.

【 授权许可】

Unknown